You can buy or sell CSBR and other stocks, options, ETFs, and crypto commission-free!
Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. Read More It uses its technology to offer solutions to Translational Oncology Solutions, which includes pharmaceutical and biotechnology companies; and Personalized Oncology, which assists physicians in developing personalized treatment options for their cancer patients. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.
Hackensack, New Jersey
52 Week High
52 Week Low
Simply Wall StMay 1
Does Champions Oncology, Inc. (NASDAQ:CSBR) Have A Particularly Volatile Share Price?
Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! If you’re interested in Champions Oncology, Inc. (NASDAQ:CSBR), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your portfolio. Volatility is considered to be a measure of risk in modern finance theory. Investors may think of volatility as falling into two main categories. The first category is company sp...